AHL Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.92M Sell
38,684
-1,078
-3% -$73.9K 1.99% 18
2025
Q2
$2.74M Sell
39,762
-298
-0.7% -$19.5K 1.83% 18
2025
Q1
$2.71M Sell
40,060
-3,256
-8% -$195K 1.87% 19
2024
Q4
$1.94M Buy
43,316
+713
+2% +$40K 1.36% 28
2024
Q3
$2.68M Buy
42,603
+100
+0.2% +$5.83K 1.85% 20
2024
Q2
$2.51M Buy
42,503
+7,767
+22% +$486K 1.84% 19
2024
Q1
$2.77M Hold
34,736
2.13% 16
2023
Q4
$2.74M Sell
34,736
-50
-0.1% -$3.56K 2.25% 15
2023
Q3
$2.43M Buy
34,786
+1,440
+4% +$102K 2.16% 17
2023
Q2
$2.31M Buy
33,346
+1,940
+6% +$138K 2.05% 17
2023
Q1
$2.33M Sell
31,406
-440
-1% -$36.9K 2.15% 14
2022
Q4
$2.97M Buy
31,846
+1,858
+6% +$179K 2.76% 12
2022
Q3
$2.86M Sell
29,988
-520
-2% -$51.5K 2.94% 13
2022
Q2
$2.83M Sell
30,508
-30
-0.1% -$2.93K 2.84% 12
2022
Q1
$3.09M Sell
30,538
-780
-2% -$81.9K 2.83% 14
2021
Q4
$3.23M Buy
+31,318
New +$2.89M 2.95% 11

Other funds holding CVS

AHL Investment Management's CVS Position: Q3 2025 in Review

AHL Investment Management reduced its CVS Health (CVS) stake by 2.7% in Q3 2025, selling an estimated $73.9K and leaving 38,684 shares worth $2.92M. The position accounts for 1.99% of the portfolio, ranked #18.

AHL Investment Management first reported a position in CVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.23M in Q4 2021. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • AHL Investment Management held 38,684 shares of CVS Health worth $2.92M as of Q3 2025.
  • AHL Investment Management sold 1,078 CVS Health shares in Q3 2025, an estimated $73.9K.
  • CVS Health made up 1.99% of AHL Investment Management's portfolio in Q3 2025, its #18 holding.
  • AHL Investment Management first reported a position in CVS Health in Q4 2021 and has held it in 16 quarters since.
  • AHL Investment Management's CVS Health position peaked at $3.23M in Q4 2021.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on AHL Investment Management's 13F filing for Q3 2025, filed 2 Oct 2025.